285 related articles for article (PubMed ID: 34667307)
21. Early Adoption of Longitudinal Surveillance for SARS-CoV-2 among Staff in Long-Term Care Facilities: Prevalence, Virologic and Sequence Analysis.
Gallichotte EN; Quicke KM; Sexton NR; Fitzmeyer E; Young MC; Janich AJ; Dobos K; Pabilonia KL; Gahm G; Carlton EJ; Ebel GD; Ehrhart N
Microbiol Spectr; 2021 Dec; 9(3):e0100321. PubMed ID: 34756092
[TBL] [Abstract][Full Text] [Related]
22. Higher Viral Load Drives Infrequent Severe Acute Respiratory Syndrome Coronavirus 2 Transmission Between Asymptomatic Residence Hall Roommates.
Bjorkman KK; Saldi TK; Lasda E; Bauer LC; Kovarik J; Gonzales PK; Fink MR; Tat KL; Hager CR; Davis JC; Ozeroff CD; Brisson GR; Larremore DB; Leinwand LA; McQueen MB; Parker R
J Infect Dis; 2021 Oct; 224(8):1316-1324. PubMed ID: 34302469
[TBL] [Abstract][Full Text] [Related]
23. Children and Adolescents With SARS-CoV-2 Infection: Epidemiology, Clinical Course and Viral Loads.
Maltezou HC; Magaziotou I; Dedoukou X; Eleftheriou E; Raftopoulos V; Michos A; Lourida A; Panopoulou M; Stamoulis K; Papaevangelou V; Petinaki E; Mentis A; Papa A; Tsakris A; Roilides E; Syrogiannopoulos GA; Tsolia M;
Pediatr Infect Dis J; 2020 Dec; 39(12):e388-e392. PubMed ID: 33031141
[TBL] [Abstract][Full Text] [Related]
24. SARS-CoV-2 viral shedding and susceptibility: perspectives on gender and asymptomatic patients.
Engku Abd Rahman ENS; Al-Fendi AMM; Irekeola AA; Musa N; Furusawa G; Chan YY
J Infect Dev Ctries; 2022 May; 16(5):768-777. PubMed ID: 35656946
[TBL] [Abstract][Full Text] [Related]
25. Longitudinal SARS-CoV-2 seroconversion and functional heterogeneity in a pediatric dialysis unit.
Canas JJ; Starr MC; Hooks J; Arregui S; Wilson AC; Carroll AE; Saxena V; Amanat F; Krammer F; Fill J; Schade A; Chambers A; Schneider J; Schwaderer AL; Hains DS
Kidney Int; 2021 Feb; 99(2):484-486. PubMed ID: 33509357
[No Abstract] [Full Text] [Related]
26. Seroprevalence of SARS-CoV-2 antibodies among 925 staff members in an urban hospital accepting COVID-19 patients in Osaka prefecture, Japan: A cross-sectional study.
Nishida T; Iwahashi H; Yamauchi K; Kinoshita N; Okauchi Y; Suzuki N; Inada M; Abe K
Medicine (Baltimore); 2021 Jun; 100(25):e26433. PubMed ID: 34160433
[TBL] [Abstract][Full Text] [Related]
27. Persistent COVID-19 Symptoms Minimally Impact the Development of SARS-CoV-2-Specific T Cell Immunity.
Fang H; Wegman AD; Ripich K; Friberg H; Currier JR; Thomas SJ; Endy TP; Waickman AT
Viruses; 2021 May; 13(5):. PubMed ID: 34063463
[TBL] [Abstract][Full Text] [Related]
28. Down but far from out: The durability of SARS-CoV-2 immunity after asymptomatic infection.
Kedl RM
J Exp Med; 2021 May; 218(5):. PubMed ID: 33861846
[TBL] [Abstract][Full Text] [Related]
29. Systematic screening on admission for SARS-CoV-2 to detect asymptomatic infections.
Stadler RN; Maurer L; Aguilar-Bultet L; Franzeck F; Ruchti C; Kühl R; Widmer AF; Schindler R; Bingisser R; Rentsch KM; Pargger H; Sutter R; Steiner L; Meier C; Kübler W; Hirsch HH; Egli A; Battegay M; Bassetti S; Tschudin-Sutter S
Antimicrob Resist Infect Control; 2021 Feb; 10(1):44. PubMed ID: 33640031
[TBL] [Abstract][Full Text] [Related]
30. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
[TBL] [Abstract][Full Text] [Related]
31. Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study.
Adler L; Gazit S; Pinto Y; Perez G; Mizrahi Reuveni M; Yehoshua I; Hoffman R; Azuri J; Patalon T
Scand J Prim Health Care; 2022 Sep; 40(3):342-349. PubMed ID: 36314555
[TBL] [Abstract][Full Text] [Related]
32. Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection.
Reynolds CJ; Swadling L; Gibbons JM; Pade C; Jensen MP; Diniz MO; Schmidt NM; Butler DK; Amin OE; Bailey SNL; Murray SM; Pieper FP; Taylor S; Jones J; Jones M; Lee WJ; Rosenheim J; Chandran A; Joy G; Di Genova C; Temperton N; Lambourne J; Cutino-Moguel T; Andiapen M; Fontana M; Smit A; Semper A; O'Brien B; Chain B; Brooks T; Manisty C; Treibel T; Moon JC; ; Noursadeghi M; ; Altmann DM; Maini MK; McKnight Á; Boyton RJ
Sci Immunol; 2020 Dec; 5(54):. PubMed ID: 33361161
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Kang CK; Kim M; Lee S; Kim G; Choe PG; Park WB; Kim NJ; Lee CH; Kim IS; Jung K; Lee DS; Shin HM; Kim HR; Oh MD
J Infect Dis; 2021 Jul; 224(1):39-48. PubMed ID: 33755725
[TBL] [Abstract][Full Text] [Related]
34. Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions.
Peluso MJ; Donatelli J; Henrich TJ
Transl Res; 2022 Mar; 241():1-12. PubMed ID: 34780969
[TBL] [Abstract][Full Text] [Related]
35. The long road.
Cohen J
Science; 2021 Feb; 371(6531):768-772. PubMed ID: 33602838
[No Abstract] [Full Text] [Related]
36. Determinants and Dynamics of SARS-CoV-2 Infection in a Diverse Population: 6-Month Evaluation of a Prospective Cohort Study.
Horton DB; Barrett ES; Roy J; Gennaro ML; Andrews T; Greenberg P; Bruiners N; Datta P; Ukey R; Velusamy SK; Fine D; Honnen WJ; Yin YS; Pinter A; Brooks A; Tischfield J; Hussain S; Jagpal S; Swaminathan S; Parmar V; Reilly N; Gaur S; Panettieri RA; Carson JL; Blaser MJ
J Infect Dis; 2021 Oct; 224(8):1345-1356. PubMed ID: 34387310
[TBL] [Abstract][Full Text] [Related]
37. Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2.
Meyerowitz EA; Richterman A; Bogoch II; Low N; Cevik M
Lancet Infect Dis; 2021 Jun; 21(6):e163-e169. PubMed ID: 33301725
[TBL] [Abstract][Full Text] [Related]
38. COVID-19 - pathogenesis and immunological findings across the clinical manifestation spectrum.
Carsetti R; Quinti I; Locatelli F
Curr Opin Pulm Med; 2021 May; 27(3):193-198. PubMed ID: 33629970
[TBL] [Abstract][Full Text] [Related]
39. Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England.
Wells PM; Doores KJ; Couvreur S; Nunez RM; Seow J; Graham C; Acors S; Kouphou N; Neil SJD; Tedder RS; Matos PM; Poulton K; Lista MJ; Dickenson RE; Sertkaya H; Maguire TJA; Scourfield EJ; Bowyer RCE; Hart D; O'Byrne A; Steel KJA; Hemmings O; Rosadas C; McClure MO; Capedevilla-Pujol J; Wolf J; Ourselin S; Brown MA; Malim MH; Spector T; Steves CJ
J Infect; 2020 Dec; 81(6):931-936. PubMed ID: 33068628
[TBL] [Abstract][Full Text] [Related]
40. Dysregulation of Innate and Adaptive Immune Responses in Asymptomatic SARS-CoV-2 Infection with Delayed Viral Clearance.
Cao S; Zhang Q; Song L; Xiao M; Chen Y; Wang D; Li M; Hu J; Lin L; Zheng Y; Zhou K; Ye S; Zhou J; Zhou YN; Cui J; Wang J; Sun J; Tao J; Chen Z; Chen R; Zhou P; Shi Z; Wei S; Zhao L; Wang H; Tong X; Li X; Men D; Hou B; Zhang XE
Int J Biol Sci; 2022; 18(12):4648-4657. PubMed ID: 35874943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
